Related Experiment Video
Updated: Jun 9, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Association between inflammatory burden index and coronary slow flow phenomenon in patients with chest pain and no
Zhi-Gao Wen1, Jun-Jie Long2, Yong Wang3
1Department of Emergency Medicine, Shenzhen Luohu Hospital Group Luohu People's Hospital, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China. jzwenzhigao@163.com.
Insights
The inflammatory burden index (IBI) may predict coronary slow flow phenomenon (CSFP) in patients with chest pain. Higher IBI levels indicate a greater risk of developing CSFP, improving diagnostic capabilities.
Area of Science:
- Cardiology
- Inflammation Biomarkers
- Coronary Artery Disease
Background:
- The inflammatory burden index (IBI) is a novel indicator associated with various diseases.
- Few studies have explored the relationship between IBI and coronary slow flow phenomenon (CSFP).
Purpose of the Study:
- To investigate the predictive value of IBI for CSFP in patients presenting with chest pain and no obstructive coronary artery disease.
Main Methods:
- 1126 individuals with chest pain and no obstructive coronary arteries were included.
- IBI was determined using plasma C-reactive protein, neutrophil, and lymphocyte counts.
- A 1:2 age- and sex-matched control group was established.
Main Results:
- IBI was significantly higher in the CSFP group (21.1 ± 6.5) compared to controls (14.5 ± 6.4).
- IBI and body mass index were identified as independent predictors of CSFP.
- An IBI cutoff of >15.74 showed 77.5% sensitivity and 67.6% specificity for CSFP (AUC = 0.799).
Conclusions:
- IBI may serve as an independent predictor of CSFP in patients with chest pain and normal coronary arteries.
- IBI can enhance the predictive value for CSFP beyond traditional indicators.
Background:
The inflammatory burden index (IBI), a novel inflammation-based indicator, to is associated with the presence and prognosis of various diseases. However, few studies have focused on exploring the relationship between IBI and the coronary slow flow phenomenon (CSFP). In this study, we aimed to investigate the predictive value of IBI for CSFP in patients with chest pain and no obstructive coronary artery disease.
Methods:
A total of 1126 individuals with chest pain and no obstructive coronary arteries were consecutively included in this study. 71 patients developed CSFP were included in the CSFP group. A 1:2 age- and sex-matched patient with normal blood flow and angiographically proven normal coronary arteries was selected as the control group (n = 142). Plasma C-reactive protein (CRP), neutrophil, and lymphocyte counts were measured to determine the value of IBI.
Results:
The IBI were significantly higher in the CSFP group than in the controls (21.1 ± 6.5 vs. 14.5 ± 6.4, P < 0.001). The IBI increasedelevated with the increase of the numbers of vessels affected by CSFP. Multivariate logistic regression analysis revealed that IBI and body mass index (BMI) were independent predictors of CSFP. Receiver operating characteristic (ROC) curve analysis showed that when IBI was > 15.74, the sensitivity and specificity were 77.5% and 67.6%, respectively, and the area under the ROC curve (AUC) was 0.799 (95% CI: 0.737-0.862, P<0.001).
Conclusion:
The IBI may be an independent predictor of CSFP in patients with chest pain and normal coronary arteries. The IBI could improve the predictive value of CSFP compared with the indicators alone.
More Related Videos
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Related Concept Videos
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Coronary Artery Disease II: Pathophysiology